Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 6Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 69OTHER_GOV 3INDUSTRY 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Stomach Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 9Drug Therapy 9Bevacizumab 9Radiotherapy 8Carboplatin 8Oxaliplatin 7Cyclophosphamide 7Surgical Procedures, Operative 6Cisplatin 6Capecitabine 6tislelizumab 5Paclitaxel 5Fluorouracil 5Docetaxel 5Control Groups 5Nivolumab 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3fludarabine 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Neoadjuvant Therapy × Clear all
NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting
220 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06035250 2023-09-28

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

Chinese Academy of Sciences

Recruiting
200 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04138212 2022-08-09

HCHTOG1903

Henan Cancer Hospital

Phase 3 Recruiting
456 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡